Skip to main content

Alyeska Investment Group, L.P.

Position in SRZN — Surrozen, Inc./DE

CIK 1453072 CHICAGO, IL

Position in SRZN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$264,378
-$32,398 QoQ
Shares Held
10,188
0.0% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#42
of 70 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SRZN Over Time

Shares Held

Position Value (USD)

Derivatives in SRZN

reported options exposure · as of Jun 30, 2024
CallValue
$2,737,500
CallShares
250,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $989,063,778 across 83 Biotechnology names. SRZN ranks #79 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRZN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $264,378 10,188
2026-03-31 $296,776 10,188
2025-12-31 $230,248 10,188
2025-09-30 $131,272 10,188
2025-06-30 $91,080 10,188
2025-03-31 $118,792 10,188
2024-12-31 $146,197 10,188
2024-09-30 $244,104 20,376
2024-06-30 $223,117 20,376
2024-06-30 $2,737,500 250,000
2024-03-31 $320,106 20,376
2023-12-31 $191,534 20,376
2023-12-31 $2,350,000 250,000
2023-09-30 $149,767 305,648
2023-03-31 $184,000 305,648
2022-12-31 $177,887 305,648
2022-09-30 $617,408 305,648
2022-06-30 $916,944 305,648
2022-03-31 $920,000 305,648
2021-12-31 $2,554,928 396,728
2021-09-30 $3,540,000 500,000
2021-06-30 CHFW 250,002
2021-03-31 CHFW 250,002